Laser surgical treatment of intrauterine synechiae in patients with a complicated obstetric and gynecological history: a STROBE-based analysis
- Authors: Obosyan L.B.1, Spirina E.I.1, Ulanova V.S.1, Muraveva S.S.1, Dzhibladze T.A.1, Svidinskaya E.A.1, Bortsvadze S.N.1, Zuev V.M.1, Khokhlova I.D.1
-
Affiliations:
- I.M. Sechenov First Moscow State Medical University
- Issue: Vol 12, No 2 (2025)
- Pages: 224-234
- Section: Original study articles
- URL: https://ogarev-online.ru/2313-8726/article/view/310280
- DOI: https://doi.org/10.17816/aog646305
- EDN: https://elibrary.ru/KSNVOZ
- ID: 310280
Cite item
Abstract
Background: Uterine factor accounts for up to 15% of female infertility cases, and the prevalence of intrauterine synechiae and Asherman syndrome is increasing due to the growing number of intrauterine procedures. Despite the availability of effective treatments, the risk of Asherman syndrome recurrence remains high, reaching 30%–66% after various surgical interventions. One of the current challenges in medicine is the development of more effective methods aimed at suppressing fibrosis, stimulating regeneration, and restoring functional endometrium.
Aim: To evaluate the effectiveness of a comprehensive approach to the surgical treatment of patients with intrauterine synechiae and Asherman syndrome in the context of a compromised obstetric and gynecological history.
Methods: A retrospective cohort study was conducted at the V.F. Snegirev Clinic of Obstetrics and Gynecology, Sechenov University. Medical records of 32 patients with uterine infertility due to intrauterine synechiae or Asherman syndrome treated between 2014 and 2021 were analyzed. The diagnosis was based on the results of pelvic ultrasound and office hysteroscopy. The study included patients with complicated obstetric and gynecological history, including pregnancy loss, multiple intrauterine interventions, complicated deliveries, and postpartum complications. Destruction of intrauterine synechiae was performed using laser energy, followed by intrauterine administration of an anti-adhesion gel. Follow-up office hysteroscopy was performed at 3 and 6 months postoperatively to assess treatment outcomes.
Results: Long-term surgical outcomes were obtained in 294 (90.0%) patients. At 3- and 6-month follow-ups, isolated intrauterine adhesions were identified in 20 (6.7%) patients, 18 of which underwent repeat hysteroscopy with laser adhesiolysis and intrauterine gel administration, while two required a three-stage hysteroscopic laser adhesiolysis. No recurrence of synechiae was observed among patients who received intrauterine anti-adhesion gel. Of 178 patients with menstrual disorders, restoration of regular cycles was reported in 136 (76.0%), whereas 42 (24.0%) reported light but regular menstruation. Within one year, 300 patients planned pregnancy; follow-up data were obtained for 239, and 155 (65.0%) reported conception, with 132 resulting in childbirth. A total of 46 patients continued treatment at assisted reproductive technology clinics.
Conclusion: Laser adhesiolysis followed by intrauterine anti-adhesion gel administration demonstrated high effectiveness (by reducing recurrence rates, restoring menstrual function, and increasing the likelihood of pregnancy). These findings highlight the importance of a comprehensive approach to timely diagnosis, treatment, and prevention of synechiae to improve the reproductive health of patients.
Full Text
##article.viewOnOriginalSite##About the authors
Lilia B. Obosyan
I.M. Sechenov First Moscow State Medical University
Email: borisovna77510@gmail.com
ORCID iD: 0000-0002-1316-6291
Russian Federation, Moscow
Ekaterina I. Spirina
I.M. Sechenov First Moscow State Medical University
Email: spirina.ekat2014@yandex.ru
ORCID iD: 0009-0003-3183-0306
Russian Federation, Moscow
Valeriia S. Ulanova
I.M. Sechenov First Moscow State Medical University
Email: lera.nikiforova@gmail.com
ORCID iD: 0009-0009-7134-4189
Russian Federation, Moscow
Svetlana S. Muraveva
I.M. Sechenov First Moscow State Medical University
Email: mursvet01@bk.ru
ORCID iD: 0009-0001-2014-2458
Russian Federation, Moscow
Tea A. Dzhibladze
I.M. Sechenov First Moscow State Medical University
Email: djiba@bk.ru
ORCID iD: 0000-0003-1540-5628
SPIN-code: 5688-1084
MD, Dr. Sci. (Medicine), Professor
Russian Federation, MoscowEvgeniya A. Svidinskaya
I.M. Sechenov First Moscow State Medical University
Author for correspondence.
Email: svidinskaya@gmail.com
ORCID iD: 0000-0002-2368-1932
MD, Cand. Sci. (Medicine)
Russian Federation, MoscowShorena N. Bortsvadze
I.M. Sechenov First Moscow State Medical University
Email: shorena.b@list.ru
ORCID iD: 0000-0003-2085-601X
MD, Cand. Sci. (Medicine)
Russian Federation, MoscowVladimir M. Zuev
I.M. Sechenov First Moscow State Medical University
Email: vlzuev@bk.ru
ORCID iD: 0000-0001-8715-2020
SPIN-code: 2857-0309
MD, Dr. Sci. (Medicine), Professor
Russian Federation, MoscowIrina D. Khokhlova
I.M. Sechenov First Moscow State Medical University
Email: irhohlova5@gmail.com
ORCID iD: 0000-0001-8547-6750
SPIN-code: 6858-5235
MD, Cand. Sci. (Medicine), Assistant Professor
Russian Federation, MoscowReferences
- Davydov AI, Volkova SV, Pashkov VM, Klindukhov IA. The “Web” of intrauterine synechiae: from etiology to prevention. Gynecology, Obstetrics and Perinatology. 2017;16(2):65–73. doi: 10.20953/1726-1678-2017-2-65-73 EDN: YRYXKV
- Queckbörner S, Syk Lundberg E, Gemzell-Danielsson K, Davies LC. Endometrial stromal cells exhibit a distinct phenotypic and immunomodulatory profile. Stem Cell Res Ther. 2020;11(1):15. doi: 10.1186/s13287-019-1496-2
- Sallée C, Margueritte F, Marquet P, et al. Uterine factor infertility, a systematic review. J Clin Med. 2022;11(16):4907. doi: 10.3390/jcm11164907
- Glukhov EYu, Dikke GB, Neff EI, et al. Experience of complex therapy in the treatment of patients with Asherman’s syndrome. Farmateka. 2021;28(6):64–70. doi: 10.18565/pharmateca.2021.6.64-70 EDN: ZEBDYZ
- Hansen BB, Nøhr B. Surgical treatment of Asherman syndrome and reproductive outcome. Dan Med J. 2022;69(3):A09210736.
- Tafti SZG, Javaheri A, Firoozabadi RD, et al. Role of hyaluronic acid intrauterine injection in the prevention of Asherman’s syndrome in women undergoing uterine septum resection: An RCT. Int J Reprod Biomed. 2021;19(4):339–346. doi: 10.18502/ijrm.v19i4.9060
- Conforti A, Alviggi C, Mollo A, et al. The management of Asherman syndrome: a review of literature. Reprod Biol Endocrinol. 2013;11:118. doi: 10.1186/1477-7827-11-118
- Rodríguez-Eguren A, Bueno-Fernandez C, Gómez-Álvarez M, et al. Evolution of biotechnological advances and regenerative therapies for endometrial disorders: a systematic review. Hum Reprod Update. 2024;30(5):584–613. doi: 10.1093/humupd/dmae013
- Johary J, Xue M, Zhu X, et al. Efficacy of estrogen therapy in patients with intrauterine adhesions: systematic review. J Minim Invasive Gynecol. 2014;21(1):44–54. doi: 10.1016/j.jmig.2013.07.018
- Zhang SS, Xia WT, Xu J, et al. Three-dimensional structure micelles of heparin-poloxamer improve the therapeutic effect of 17β-estradiol on endometrial regeneration for intrauterine adhesions in a rat model. Int J Nanomedicine. 2017;12:5643–5657. doi: 10.2147/IJN.S137237
- Dobrokhotova YuE, Grishin II, Grishin AI, Komagorov VI. Use of anti-adhesion gels for intrauterine surgery. Russian Journal of Woman and Child Health. 2018;1(1):71–75. doi: 10.32364/2618-8430-2018-1-1-71-75 EDN: YAIZIL
- Lee WL, Liu CH, Cheng M, et al. Focus on the primary prevention of intrauterine adhesions: current concept and vision. Int J Mol Sci. 2021;22(10):5175. doi: 10.3390/ijms22105175
- Molotkov AS, Popov EN, Sudakov DS, et al. Experience of intrauterine use of hyaluronic acid-based anti-adhesion gel for the prevention of Asherman’s syndrome in patients with uterine cavity pathology and severe forms of endometriosis. Journal of Obstetrics and Womans Diseases. 2017;66(6):12–19. doi: 10.17816/JOWD66612-19 EDN: YKWEAW
- Kravtsova EI, Kutsenko II, Kholina LA, Anikina GA. Efficacy of proteolytic therapy in the comprehensive management of patients with second-degree intrauterine synechia. Medical Council. 2020;(3):170–175. doi: 10.21518/2079-701X-2020-3-170-175 EDN: ANRRDF
- AAGL Elevating Gynecologic Surgery. AAGL practice report: practice guidelines on intrauterine adhesions developed in collaboration with the European Society of Gynaecological Endoscopy (ESGE). Gynecol Surg. 2017;14(1):6. doi: 10.1186/ s10397-017-1007-3
- Health care in Russia: 2023. Moscow: Stat. sb. Rosstat; 2023. 179 p. (In Russ.)
- Ma J, Zhan H, Li W, et al. Recent trends in therapeutic strategies for repairing endometrial tissue in intrauterine adhesion. Biomater Res. 2021;25(1):40. doi: 10.1186/s40824-021-00242-6
- Zuev VM, Kalinina EA, Kukushkin VI, et al. Innovative laser technologies in the diagnosis and treatment of “problem” endometrium in reproductive medicine. Akusherstvo i Ginekologiya. 2020;(4):157–165. doi: 10.18565/aig.2020.4.157-165 EDN: IQOFPF
- Khan Z, Goldberg JM. Hysteroscopic management of Asherman’s syndrome. J Minim Invasive Gynecol. 2018;25(2):218–228. doi: 10.1016/j.jmig.2017.09.020
- Dzhibladze TA, Svidinskaya EA, Bortsvadze ShN, et al. Intrauterine synechiae and Asherman’s syndrome: an integrated approach to diagnosis and treatment. Gynecology, Obstetrics and Perinatology. 2021;20(5):43–50. doi: 10.20953/1726-1678-2021-5-43-50 EDN: CFUMEF
- Freedman MF, Schlaff WD. Avoiding Asherman’s syndrome: refining our approach to uterine evacuation. Fertil Steril. 2021;116(4):961–962. doi: 10.1016/j.fertnstert.2021.06.037
- Vitale SG, Buzzaccarini G, Riemma G, et al. Endometrial biopsy: Indications, techniques and recommendations. An evidence-based guideline for clinical practice. J Gynecol Obstet Hum Reprod. 2023;52(6):102588. doi: 10.1016/j.jogoh.2023.102588
- Bortsvadze ShN, Dzhibladze TA, Ishchenko AI. Infertility in women with intrauterine synechiae: modern aspects of diagnosis. Gynecology, Obstetrics and Perinatology. 2013;12(5):11–15. EDN: RGQZJB
- Jegaden M, Bleas C, Debras E, et al. Asherman syndrome after uterine artery embolization: a cohort study about surgery management and fertility outcomes. J Minim Invasive Gynecol. 2023;30(6):494–501. doi: 10.1016/j.jmig.2023.02.012
- Suh J, Choo MS, Oh S-J. Efficacy and safety of low power holmium laser enucleation of the prostate: A prospective short- and medium-term single-blind randomized trial. Investig Clin Urol. 2023;64(5):480–488. doi: 10.4111/icu.20230017
- Bhatta N, Isaacson K, Bhatta KM, et al. Comparative study of different laser systems. Fertil Steril. 1994;61(4):581–591. doi: 10.1016/s0015-0282(16)56629-1
- ESGE Special Interest Group ‘Innovations’ Working Group. Lasers in gynaecology — Are they still obsolete? Review of past, present and future applications. Facts Views Vis Obgyn. 2020;12(1):63–66.
Supplementary files
